Juul A
Department of Growth and Reproduction GR, Rigshospitalet, University of Copenhagen, Denmark.
Hum Reprod Update. 2001 May-Jun;7(3):303-13. doi: 10.1093/humupd/7.3.303.
Regulation of linear bone growth in children and adolescents comprises a complex interaction of hormones and growth factors. Growth hormone (GH) is considered to be the key hormone regulator of linear growth in childhood. The pubertal increase in growth velocity associated with GH has traditionally been attributed to testicular androgen secretion in boys, and to oestrogens or adrenal androgen secretion in girls. Research data indicating that oestrogen may be the principal hormone stimulating the pubertal growth spurt in boys as well as girls is reviewed. Such an action is mediated by oestrogen receptors (ER-alpha and ER-beta) in the human growth plate, and polymorphisms in the ER gene may influence adult height in healthy subjects. Prepubertal oestradiol concentrations are significantly higher in girls than in boys, explaining sex-related differences in pubertal onset. Men with a disruptive mutation in the ER gene (oestrogen resistance) or in the CYP19 gene (aromatase deficiency) who have no pubertal growth spurt and continue to grow into adulthood due to lack of epiphyseal fusion supports this notion. Furthermore, phenotypic females with complete androgen insensitivity syndrome have a normal female growth spurt despite lack of androgen action. Oestrogens may also influence linear bone growth indirectly via modulation of the GH-insulin-like growth factor-I (IGF-I) axis. Thus, ER blockade diminishes endogenous GH secretion, androgen receptor (AR) blockade increases GH secretion in peripubertal boys, and non-aromatizable androgens [oxandrolone or dihydrotestosterone (DHT)] have no effect on GH secretion. Treatment with aromatase inhibitors reduces circulating IGF-I concentrations in healthy males, and reduces growth in boys with testotoxicosis. Taken together, these findings suggest that oestrogens may, in addition to their direct effects, stimulate GH secretion and thereby increase circulating IGF-I, which in turn may stimulate growth. Thus, oestrogens have important biphasic actions on longitudinal growth in boys as well as in girls. Very low levels of oestrogens may stimulate bone growth without affecting sexual maturation directly at the growth plate as well as through stimulation of the GH-IGF axis, which in turn may stimulate growth. Conversely, higher levels of oestrogens stimulate secondary sexual characteristics and epiphyseal fusion.
儿童和青少年线性骨生长的调节包括激素和生长因子的复杂相互作用。生长激素(GH)被认为是儿童期线性生长的关键激素调节因子。传统上,与GH相关的青春期生长速度增加归因于男孩的睾丸雄激素分泌,以及女孩的雌激素或肾上腺雄激素分泌。本文综述了表明雌激素可能是刺激男孩和女孩青春期生长突增的主要激素的研究数据。这种作用是由人类生长板中的雌激素受体(ER-α和ER-β)介导的,ER基因的多态性可能会影响健康受试者的成年身高。青春期前女孩的雌二醇浓度显著高于男孩,这解释了青春期开始的性别差异。在ER基因(雌激素抵抗)或CYP19基因(芳香化酶缺乏)中存在破坏性突变的男性,由于缺乏骨骺融合而没有青春期生长突增,并持续生长至成年,这支持了这一观点。此外,患有完全雄激素不敏感综合征的表型女性尽管缺乏雄激素作用,但仍有正常的女性生长突增。雌激素还可能通过调节GH-胰岛素样生长因子-I(IGF-I)轴间接影响线性骨生长。因此,ER阻断会减少内源性GH分泌,雄激素受体(AR)阻断会增加青春期前男孩的GH分泌,而不可芳香化的雄激素[氧雄龙或二氢睾酮(DHT)]对GH分泌没有影响。芳香化酶抑制剂治疗可降低健康男性的循环IGF-I浓度,并减少患有睾丸中毒症男孩的生长。综上所述,这些发现表明,雌激素除了具有直接作用外,还可能刺激GH分泌,从而增加循环IGF-I,进而可能刺激生长。因此,雌激素对男孩和女孩的纵向生长具有重要的双相作用。极低水平的雌激素可能刺激骨骼生长,而不会直接影响生长板处的性成熟,也不会通过刺激GH-IGF轴来影响生长,而GH-IGF轴反过来又可能刺激生长。相反,较高水平的雌激素会刺激第二性征和骨骺融合。